Suppr超能文献

肾功能障碍与导管消融术后心房颤动患者发生血栓栓塞事件的风险——CHA₂DS₂-VASc 评分之外的潜在作用。

Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score.

机构信息

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Heart Rhythm. 2012 Nov;9(11):1755-60. doi: 10.1016/j.hrthm.2012.06.039. Epub 2012 Jun 30.

Abstract

BACKGROUND

Renal dysfunction is recognized as an important risk factor for thromboembolic (TE) events in patients with atrial fibrillation (AF) under medical treatment.

OBJECTIVE

To investigate whether renal dysfunction is a useful predictor of TE events among patients receiving AF ablation. We also aimed to determine whether the diagnostic accuracy of the CHA(2)DS(2)-VASc score in predicting TE events could be improved by adding renal dysfunction into the scoring system.

METHODS

We enrolled a total of 547 patients with AF who underwent catheter ablation. Renal dysfunction was defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2). The clinical end point was the occurrence of TE events (ischemic stroke, transient ischemic attack, or other systemic embolisms) during follow-up after catheter ablation.

RESULTS

During a follow-up of 38.9 ± 22.5 months, 16 patients (2.9%) experienced TE events. Both the CHA(2)DS(2)-VASc score and renal dysfunction were independent predictors of TE events in the multivariate analysis. Among patients with a CHA(2)DS(2)-VASc score of 0 or 1, renal dysfunction can further stratify them into 2 groups with different event rates (4.3% vs 0.3%; P = .046). A new scoring system derived by assigning 1 more point representing renal dysfunction to the CHA(2)DS(2)-VASc score could improve its predictive accuracy; the area under the receiver operating characteristic curve increased from 0.84 to 0.88 (P = .043).

CONCLUSIONS

Renal dysfunction was a significant risk factor for TE events after catheter ablation of AF and may improve the diagnostic accuracy of the CHA(2)DS(2)-VASc score.

摘要

背景

肾功能障碍被认为是接受药物治疗的房颤(AF)患者发生血栓栓塞(TE)事件的一个重要危险因素。

目的

研究肾功能障碍是否是接受 AF 消融治疗的患者发生 TE 事件的有用预测因子。我们还旨在确定将肾功能障碍纳入评分系统是否可以提高 CHA(2)DS(2)-VASc 评分预测 TE 事件的诊断准确性。

方法

我们共纳入了 547 例行导管消融的 AF 患者。肾功能障碍定义为估算肾小球滤过率(eGFR)<60 mL/min/1.73 m(2)。临床终点是导管消融后随访期间发生 TE 事件(缺血性卒、短暂性脑缺血发作或其他全身性栓塞)。

结果

在 38.9 ± 22.5 个月的随访期间,16 名患者(2.9%)发生了 TE 事件。CHA(2)DS(2)-VASc 评分和肾功能障碍在多变量分析中均是 TE 事件的独立预测因子。在 CHA(2)DS(2)-VASc 评分为 0 或 1 的患者中,肾功能障碍可将其进一步分为两组,两组的事件发生率不同(4.3%比 0.3%;P =.046)。通过将 1 分分配给代表肾功能障碍的 CHA(2)DS(2)-VASc 评分,可以得到一个新的评分系统,从而提高其预测准确性;ROC 曲线下面积从 0.84 增加到 0.88(P =.043)。

结论

肾功能障碍是 AF 导管消融后 TE 事件的一个重要危险因素,可能提高 CHA(2)DS(2)-VASc 评分的诊断准确性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验